Trial Outcomes & Findings for RAAS and Arterial Stiffness in SCI (NCT NCT04510974)

NCT ID: NCT04510974

Last Updated: 2025-02-20

Results Overview

Determine average pulse wave velocity among the three groups.

Recruitment status

COMPLETED

Target enrollment

33 participants

Primary outcome timeframe

2 years

Results posted on

2025-02-20

Participant Flow

Participant milestones

Participant milestones
Measure
Cervical SCI
Ages between 21-70 years old Injured between C1-T1 Wheelchair dependent AIS classification of A, B or C Injury occurred more than 1 year ago Spinal Cord Injury: Spinal Cord Injury
Thoracic SCI
Ages between 21-70 Injured between T6-T12 Wheelchair dependent AIS classification of A, B or C Injury occurred more than 1 year ago Spinal Cord Injury: Spinal Cord Injury
Able-bodied Control
Ages between 21-70
Overall Study
STARTED
11
11
11
Overall Study
COMPLETED
11
11
11
Overall Study
NOT COMPLETED
0
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

RAAS and Arterial Stiffness in SCI

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Cervical SCI
n=11 Participants
Ages between 21-70 years old Injured between C1-T1 Wheelchair dependent AIS classification of A, B or C Injury occurred more than 1 year ago Spinal Cord Injury: Spinal Cord Injury
Thoracic SCI
n=11 Participants
Ages between 21-70 Injured between T6-T12 Wheelchair dependent AIS classification of A, B or C Injury occurred more than 1 year ago Spinal Cord Injury: Spinal Cord Injury
Able-bodied Control
n=11 Participants
Ages between 21-70
Total
n=33 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
Age, Categorical
Between 18 and 65 years
11 Participants
n=5 Participants
11 Participants
n=7 Participants
11 Participants
n=5 Participants
33 Participants
n=4 Participants
Age, Categorical
>=65 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
Age, Continuous
45 years
STANDARD_DEVIATION 13 • n=5 Participants
43 years
STANDARD_DEVIATION 11 • n=7 Participants
45 years
STANDARD_DEVIATION 13 • n=5 Participants
44 years
STANDARD_DEVIATION 12 • n=4 Participants
Sex: Female, Male
Female
3 Participants
n=5 Participants
2 Participants
n=7 Participants
2 Participants
n=5 Participants
7 Participants
n=4 Participants
Sex: Female, Male
Male
8 Participants
n=5 Participants
9 Participants
n=7 Participants
9 Participants
n=5 Participants
26 Participants
n=4 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
2 Participants
n=5 Participants
0 Participants
n=7 Participants
1 Participants
n=5 Participants
3 Participants
n=4 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
9 Participants
n=5 Participants
11 Participants
n=7 Participants
10 Participants
n=5 Participants
30 Participants
n=4 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
Region of Enrollment
United States
11 participants
n=5 Participants
11 participants
n=7 Participants
11 participants
n=5 Participants
33 participants
n=4 Participants

PRIMARY outcome

Timeframe: 2 years

Determine average pulse wave velocity among the three groups.

Outcome measures

Outcome measures
Measure
Cervical SCI
n=11 Participants
Ages between 21-70 years old Injured between C1-T1 Wheelchair dependent AIS classification of A, B or C Injury occurred more than 1 year ago Spinal Cord Injury: Spinal Cord Injury
Thoracic SCI
n=11 Participants
Ages between 21-70 Injured between T6-T12 Wheelchair dependent AIS classification of A, B or C Injury occurred more than 1 year ago Spinal Cord Injury: Spinal Cord Injury
Able-bodied Control
n=11 Participants
Ages between 21-70
Pulse Wave Velocity (m/s)
8.81 m/s
Standard Deviation 1.91
7.36 m/s
Standard Deviation 1.58
5.53 m/s
Standard Deviation 0.95

SECONDARY outcome

Timeframe: 2 years

Determine differences in blood pressure among groups

Outcome measures

Outcome measures
Measure
Cervical SCI
n=11 Participants
Ages between 21-70 years old Injured between C1-T1 Wheelchair dependent AIS classification of A, B or C Injury occurred more than 1 year ago Spinal Cord Injury: Spinal Cord Injury
Thoracic SCI
n=11 Participants
Ages between 21-70 Injured between T6-T12 Wheelchair dependent AIS classification of A, B or C Injury occurred more than 1 year ago Spinal Cord Injury: Spinal Cord Injury
Able-bodied Control
n=11 Participants
Ages between 21-70
Systolic Blood Pressure (mmHg)
95 mmHg
Standard Deviation 20
125 mmHg
Standard Deviation 14
128 mmHg
Standard Deviation 27

SECONDARY outcome

Timeframe: 2 years

Determine differences in plasma renin among the groups

Outcome measures

Outcome measures
Measure
Cervical SCI
n=11 Participants
Ages between 21-70 years old Injured between C1-T1 Wheelchair dependent AIS classification of A, B or C Injury occurred more than 1 year ago Spinal Cord Injury: Spinal Cord Injury
Thoracic SCI
n=11 Participants
Ages between 21-70 Injured between T6-T12 Wheelchair dependent AIS classification of A, B or C Injury occurred more than 1 year ago Spinal Cord Injury: Spinal Cord Injury
Able-bodied Control
n=11 Participants
Ages between 21-70
Plasma Renin (pg/ml)
24.9 pg/mL
Standard Deviation 13.9
21.9 pg/mL
Standard Deviation 18
16.0 pg/mL
Standard Deviation 7.4

SECONDARY outcome

Timeframe: 2 years

Determine differences in plasma norepinephrine among the groups.

Outcome measures

Outcome measures
Measure
Cervical SCI
n=11 Participants
Ages between 21-70 years old Injured between C1-T1 Wheelchair dependent AIS classification of A, B or C Injury occurred more than 1 year ago Spinal Cord Injury: Spinal Cord Injury
Thoracic SCI
n=11 Participants
Ages between 21-70 Injured between T6-T12 Wheelchair dependent AIS classification of A, B or C Injury occurred more than 1 year ago Spinal Cord Injury: Spinal Cord Injury
Able-bodied Control
n=11 Participants
Ages between 21-70
Norepinephrine (pg/ml)
176.0 pg/mL
Standard Deviation 90.0
515.6 pg/mL
Standard Deviation 162.3
371.8 pg/mL
Standard Deviation 118.3

Adverse Events

Cervical SCI

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Thoracic SCI

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Able-bodied Control

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Caitlyn Peters

James J Peters VA Medical Center

Phone: 9733243588

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place